Current concepts on predictors of atrial fibrillation occurrence and progression
DOI:
https://doi.org/10.14739/2310-1210.2021.6.232397Keywords:
atrial fibrillation, complications, mortality, predictorsAbstract
The aim was to summarize and present a current views on the clinical, electrophysiological, hemodynamic and neurohumoral predictors of atrial fibrillation occurrence and progression by reviewing contemporary specialized literature. Atrial fibrillation has been shown to be the most common cardiac arrhythmia in clinical practice, associated with an increased risk of thromboembolic complications and cardiovascular mortality. However, there is no optimal prognostic marker for this type of arrhythmia onset and progression.
Conclusions. It has been established that the main predictors of atrial fibrillation and its complications are electrophysiological, structural and functional changes of the heart with underlying neurohumoral and pro-inflammatory activation, hypercoagulation and genetic predisposition.
References
Atlas Writing Group, ESC Atlas of Cardiology is a compendium of cardiovascular statistics compiled by the European Heart Agency, a department of the European Society of Cardiology, Developed in collaboration with the national societies of the European Society of Cardiology member countries, Timmis, A., Townsend, N., Gale, C. P., Torbica, A., Lettino, M., Petersen, S. E., Mossialos, E. A., Maggioni, A. P., Kazakiewicz, D., May, H. T., De Smedt, D., Flather, M., Zuhlke, L., Beltrame, J. F., Huculeci, R., Tavazzi, L., Hindricks, G., … Vardas, P. (2020). European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary). European Heart Journal - Quality of Care & Clinical Outcomes, 6(1), 7-9. https://doi.org/10.1093/ehjqcco/qcz065
Ugowe, F. E., & Jackson, L. R., 2nd. (2019). Atrial fibrillation and mortality risk: seeing the big picture. European Heart Journal - Quality of Care & Clinical Outcomes, 5(1), 6-7. https://doi.org/10.1093/ehjqcco/qcy050
Tomasdottir, M., Friberg, L., Hijazi, Z., Lindbäck, J., & Oldgren, J. (2019). Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation. Clinical Cardiology, 42(10), 1003-1009. https://doi.org/10.1002/clc.23257
Meyre, P., Blum, S., Berger, S., Aeschbacher, S., Schoepfer, H., Briel, M., Osswald, S., & Conen, D. (2019). Risk of Hospital Admissions in Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology, 35(10), 1332-1343. https://doi.org/10.1016/j.cjca.2019.05.024
Sepehri Shamloo, A., Dagres, N., Müssigbrodt, A., Stauber, A., Kircher, S., Richter, S., Dinov, B., Bertagnolli, L., Husser-Bollmann, D., Bollmann, A., Hindricks, G. & Arya, A. (2020). Atrial Fibrillation and Cognitive Impairment: New Insights and Future Directions. Heart, Lung and Circulation, 29(1), 69-85. https://doi.org/10.1016/j.hlc.2019.05.185
Ziff, O. J., Carter, P. R., McGowan, J., Uppal, H., Chandran, S., Russell, S., Bainey, K. R., & Potluri, R. (2018). The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry. International Journal of Cardiology, 252, 117-121. https://doi.org/10.1016/j.ijcard.2017.06.033
Pastori, D., Pignatelli, P., Menichelli, D., Violi, F., & Lip, G. (2019). Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. Mayo Clinic Proceedings, 94(7), 1261-1267. https://doi.org/10.1016/j.mayocp.2018.10.022
Alkhouli, M., & Friedman, P. A. (2019). Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. Journal of the American College of Cardiology, 74(24), 3050-3065. https://doi.org/10.1016/j.jacc.2019.10.040
Wu, V. C., Wu, M., Aboyans, V., Chang, S. H., Chen, S. W., Chen, M. C., Wang, C. L., Hsieh, I. C., Chu, P. H., & Lin, Y. S. (2020). Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation. Heart, 106(7), 534-540. https://doi.org/10.1136/heartjnl-2019-315065
Kim, T. H., Yang, P. S., Yu, H. T., Jang, E., Uhm, J. S., Kim, J. Y., Pak, H. N., Lee, M. H., Joung, B., & Lip, G. (2018). Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation. Stroke, 49(8), 1872-1879. https://doi.org/10.1161/STROKEAHA.118.021047
Chao, T. F., Lip, G., Liu, C. J., Lin, Y. J., Chang, S. L., Lo, L. W., Hu, Y. F., Tuan, T. C., Liao, J. N., Chung, F. P., Chen, T. J., & Chen, S. A. (2018). Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. Journal of the American College of Cardiology, 71(2), 122-132. https://doi.org/10.1016/j.jacc.2017.10.085
Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G., Goldhaber, S. Z., & Jensen, M. B. (2018). Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. International Journal of Cardiology, 268, 137-142. https://doi.org/10.1016/j.ijcard.2018.05.037
Decker, J. J., Norby, F. L., Rooney, M. R., Soliman, E. Z., Lutsey, P. L., Pankow, J. S., Alonso, A., & Chen, L. Y. (2019). Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study. Stroke, 50(11), 3045-3050. https://doi.org/10.1161/STROKEAHA.119.025376
Bassand, J. P., Accetta, G., Al Mahmeed, W., Corbalan, R., Eikelboom, J., Fitzmaurice, D. A., Fox, K., Gao, H., Goldhaber, S. Z., Goto, S., Haas, S., Kayani, G., Pieper, K., Turpie, A., van Eickels, M., Verheugt, F., Kakkar, A. K., & GARFIELD-AF Investigators. (2018). Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. PLOS ONE, 13(1), Article e0191592. https://doi.org/10.1371/journal.pone.0191592
Ogawa, H., An, Y., Ikeda, S., Aono, Y., Doi, K., Ishii, M., Iguchi, M., Masunaga, N., Esato, M., Tsuji, H., Wada, H., Hasegawa, K., Abe, M., Lip, G., Akao, M., & Fushimi AF Registry Investigators. (2018). Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events. Stroke, 49(10), 2301-2308. https://doi.org/10.1161/STROKEAHA.118.021396
B Schnabel, R., Pecen, L., Engler, D., Lucerna, M., Sellal, J. M., Ojeda, F. M., De Caterina, R., & Kirchhof, P. (2018). Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes. Heart, 104(19), 1608-1614. https://doi.org/10.1136/heartjnl-2017-312569
Dilaveris, P. E., & Kennedy, H. L. (2017). Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clinical Cardiology, 40(6), 413-418. https://doi.org/10.1002/clc.22667
Guerra, F., Brambatti, M., Nieuwlaat, R., Marcucci, M., Dudink, E., Crijns, H., Matassini, M. V., & Capucci, A. (2017). Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. EP Europace, 19(12), 1922-1929. https://doi.org/10.1093/europace/eux205
Shin, S. Y., Han, S. J., Kim, J. S., Im, S. I., Shim, J., Ahn, J., Lee, E. M., Park, Y. M., Kim, J. H., Lip, G., & Lim, H. E. (2019). Identification of Markers Associated With Development of Stroke in «Clinically Low-Risk» Atrial Fibrillation Patients. Journal of the American Heart Association, 8(21), Article e012697. https://doi.org/10.1161/JAHA.119.012697
Rivera-Caravaca, J. M., Marín, F., Vilchez, J. A., Gálvez, J., Esteve-Pastor, M. A., Vicente, V., Lip, G., & Roldán, V. (2019). Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. Stroke, 50(6), 1372-1379. https://doi.org/10.1161/STROKEAHA.118.024305
Oldgren, J., Hijazi, Z., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Hylek, E. M., Lopes, R. D., Siegbahn, A., Yusuf, S., Wallentin, L., & RE-LY and ARISTOTLE Investigators. (2016). Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation, 134(22), 1697-1707. https://doi.org/10.1161/CIRCULATIONAHA.116.022802
Ioannou, A., Papageorgiou, N., Falconer, D., Rehal, O., Sewart, E., Zacharia, E., Toutouzas, K., Vlachopoulos, C., Siasos, G., Tsioufis, C., & Tousoulis, D. (2019). Biomarkers Associated with Stroke Risk in Atrial Fibrillation. Current Medicinal Chemistry, 26(5), 803-823. https://doi.org/10.2174/0929867324666170718120651
Esteve-Pastor, M. A., Roldán, V., Rivera-Caravaca, J. M., Ramírez-Macías, I., Lip, G., & Marín, F. (2019). The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. Thrombosis and Haemostasis, 119(12), 1901-1919. https://doi.org/10.1055/s-0039-1696955
Petryszyn, P., Niewinski, P., Staniak, A., Piotrowski, P., Well, A., Well, M., Jeskowiak, I., Lip, G., & Ponikowski, P. (2019). Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLOS ONE, 14(3), Article e0213198. https://doi.org/10.1371/journal.pone.0213198
Mironov, N. Yu., Laiovich, L. Yu., Mironova, E. S., Sharf, T. V., Aparina, O. P., Mironova, N. A., Stukalova, O. V., Yuricheva, Yu. A., Sokolov, S. F., Novikov, I. A., Maykov, E. B., Pevzner, A. V., & Golitsyn, S. P. (2019). Novye dostizheniya v diagnostike i lechenii fibrillyatsii predserdii: ot eksperimental'nykh issledovanii do povsednevnoi klinicheskoi praktiki [Recent advances in diagnosis and management of atrial fibrillation]. Terapevticheskii arkhiv, 91(6), 11-18. https://doi.org/10.26442/00403660.2019.06.000295 [in Russian].
Mironova, E. S., Mironov, N. Yu., Mironova, N. A., Novikov, P. S., Novikov, I. A., Laiovich, L. Yu., Maikov, E. B., & Golitsyn, S. P. (2019). Elektrofiziologicheskie parametry serdtsa i rezul'taty protivoaritmicheskogo lecheniya u bol'nykh s paroksizmal'noi formoi fibrillyatsii predserdii, idiopaticheskoi i v sochetanii s gipertonicheskoi bolezn'yu [Electrophysiological Cardiac Parameters and Results of Antiarrhythmic Treatment in Patients with Paroxysmal Atrial Fibrillation (Lone and Associated with Arterial Hypertension)]. Kardiologiya, 59(8), 39-46. https://doi.org/10.18087/cardio.2019.8.n644 [in Russian].
Baranchuk, A., & Yeung, C. (2018). Advanced interatrial block predicts atrial fibrillation recurrence across different populations: Learning Bayés syndrome. International Journal of Cardiology, 272, 221-222. https://doi.org/10.1016/j.ijcard.2018.08.025
Attia, Z. I., Noseworthy, P. A., Lopez-Jimenez, F., Asirvatham, S. J., Deshmukh, A. J., Gersh, B. J., Carter, R. E., Yao, X., Rabinstein, A. A., Erickson, B. J., Kapa, S., & Friedman, P. A. (2019). An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet, 394(10201), 861-867. https://doi.org/10.1016/S0140-6736(19)31721-0
Steinhubl, S. R., Waalen, J., Edwards, A. M., Ariniello, L. M., Mehta, R. R., Ebner, G. S., Carter, C., Baca-Motes, K., Felicione, E., Sarich, T., & Topol, E. J. (2018). Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial. JAMA, 320(2), 146-155. https://doi.org/10.1001/jama.2018.8102
Khidirova, L. D., Yakhontov, D. A., & Lukinov, V. L. (2020). Personifitsirovannyi algoritm formirovaniya grupp riska progressirovaniya i razvitiya oslozhnenii fibrillyatsii predserdii pri gipertonicheskoi bolezni v sochetanii s ekstrakardial'nymi zabolevaniyami [Personalized algorithm for formation of risk groups for progression and development of complications of atrial fibrillation in hypertension in combination with extracardial diseases]. Meditsinskii alfavit, (13), 16-19. https://doi.org/10.33667/2078-5631-2020-13-16-19 [in Russian].
Solovyan, A. N. (2014). Strukturno-funktsional'noe sostoyanie miokarda, variabel'nost' ritma i elektrofiziologicheskie svoistva serdtsa u bol'nykh s paroksizmal'noi fibrillyatsiei predserdii razlichnoi etiologii [Structural and functional condition of myocardium, heart rate variability and electrophysiological heart properties in patients with paroxysmal atrial fibrillation of different genesis]. Ukrainskyi kardiolohichnyi zhurnal, (4), 84-93. [in Ukrainian].
Aparina, O. P., Chikhireva, L. N., Mironova, N. A., Mironova, E. S., & Bakalov, S. A. (2014). Rol' izmenenii struktury i funktsii predserdii v razvitii i progressirovanii fibrillyatsii predserdii [Role of atrial structural and functional changes in the development and progression of atrial fibrillation]. Terapevticheskii arkhiv, 86(1), 71-77. [in Russian].
Akramova, E. G. (2019). Klinicheskaya znachimost' prodol'noi deformatsii levogo zheludochka pri ishemicheskoi bolezni serdtsa i nekoronarogennoi patologii [Clinical significance of left ventricular longitudinal deformation in coronary heart disease and non-coronary pathology]. Kazanskii meditsinskii zhurnal, 100(2), 295-302. https://doi.org/10.17816/KMJ2019-295 [in Russian].
Friedman, D. J., Piccini, J. P., Wang, T., Zheng, J., Malaisrie, S. C., Holmes, D. R., Suri, R. M., Mack, M. J., Badhwar, V., Jacobs, J. P., Gaca, J. G., Chow, S. C., Peterson, E. D., & Brennan, J. M. (2018). Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery. JAMA, 319(4), 365-374. https://doi.org/10.1001/jama.2017.20125
Sepehri Shamloo, A., Bollmann, A., Dagres, N., Hindricks, G., & Arya, A. (2020). Natriuretic peptides: biomarkers for atrial fibrillation management. Clinical Research in Cardiology, 109(8), 957-966. https://doi.org/10.1007/s00392-020-01608-x
Borre, E. D., Goode, A., Raitz, G., Shah, B., Lowenstern, A., Chatterjee, R., Sharan, L., Allen LaPointe, N. M., Yapa, R., Davis, J. K., Lallinger, K., Schmidt, R., Kosinski, A., Al-Khatib, S. M., & Sanders, G. D. (2018). Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review. Thrombosis and Haemostasis, 118(12), 2171-2187. https://doi.org/10.1055/s-0038-1675400
Ridker, P. M., Libby, P., MacFadyen, J. G., Thuren, T., Ballantyne, C., Fonseca, F., Koenig, W., Shimokawa, H., Everett, B. M., & Glynn, R. J. (2018). Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). European Heart Journal, 39(38), 3499-3507. https://doi.org/10.1093/eurheartj/ehy310
Bubeshka, D. A., Snezhitskiy, V. A., & Shulika, V. R. (2017). Biomarkery vospaleniya u patsientov s neklapannoi fibrillyatsiei predserdii i sistolicheskoi disfunktsiei levogo zheludochka [Biomarkers of inflammation in patients with nonvalvular atrial fibrillation and left ventricular systolic dysfunction]. Meditsinskie novosti, (4), 69-72. http://www.mednovosti.by/journal.aspx?article=7987 [in Russian].
Fushtey, I. M., Podluzhnyi, S. G., & Sid’, E. V. (2020). Effect of RAAS genes polymorphism for recurrence of paroxysmal atrial fibrillation among patients with coronary heart disease combined with hypertension. Biological Markers and Guided Therapy, 7(1), 25-30. https://doi.org/10.12988/bmgt.2020.91016
Podluzhnyi, S. G. (2020). Rivni anhiotenzynu II v zalezhnosti vid polimorfizmiv A1166S, T174M u patsiientiv z paroksyzmalnoiu fibryliatsiieiu peredserd na tli IKhS ta hipertonichnoi khvoroby [Angiothiesin II Levels depending on Polymorphisms A1166C, T174M in Patients with Paroxysmal Atrial Fibrillation on the Background of Coronary Heart Disease and Hypertension]. Ukrainskyi zhurnal medytsyny, biolohii ta sportu, 5(4), P. 209-213. https://doi.org/10.26693/jmbs05.04.209 [in Ukrainian].
Podluzhnyi, S. G., Fushtey, I. M., & Sid’, E. V. (2020, September 16-18). The relative risk of left ventricular remodeling among patients with paroxysmal atrial fibrillation by gene polymorphisms renin-angiotensin-aldosterone system. Scientific Horizon in the Context of Social Crises. Proceedings of the 6th International Scientific and Practical Conference, (2), 87-89. SPC InterConf. https://ojs.ukrlogos.in.ua/index.php/interconf/article/view/4586
Getman, T. V. (2013). Znachimost' i printsipy farmakologicheskoi korrektsii aktivnosti renin-angiotenzinovoi sistemy v terapii pri fibrillyatsii predserdii [Importance and principles of pharmacological correction of renin-angiotensin system in the treatment of atrial fibrillation]. Ukrainskyi revmatolohichnyi zhurnal, (4), 105-110. [in Russian].
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)